• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

痴呆家族史对阿尔茨海默病两年病程无影响:来自REAL.FR研究的结果。

Family history of dementia does not influence the progression of Alzheimer's disease at two years: results from the REAL.FR Study.

作者信息

Cortes Frédéric, Gillette-Guyonnet Sophie, Nourhashemi Fati, Christelle Cantet, Vellas Bruno

机构信息

Service de Médecine Interne et Gérontologie Clinique, Toulouse, France.

出版信息

Am J Alzheimers Dis Other Demen. 2006 Mar-Apr;21(2):131-6. doi: 10.1177/153331750602100214.

DOI:10.1177/153331750602100214
PMID:16634470
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10833240/
Abstract

The purpose of this study was to determine whether a family history of dementia in a first-degree relative influenced the progression of Alzheimer's disease (AD) after two years of follow-up. Patients were recruited in the REAL.FR (Réseau sur la Maladie d'Alzheimer Français) study and underwent behavioral, global, nutritional, and medical evaluation with assessment of cognitive function and independence every six months. At inclusion, 113 patients reported a family history of dementia, and 358 patients had no family history of dementia. There was no statistical difference for any factors between the two groups at baseline. After two years of follow-up, a similar percentage of patients were still followed in each group, and although most parameters showed significant deterioration, there was no difference between the two groups, indicating that a family history of dementia does not appear to influence the progression of AD.

摘要

本研究的目的是确定在随访两年后,一级亲属中有痴呆家族史是否会影响阿尔茨海默病(AD)的进展。患者在法国阿尔茨海默病研究网络(REAL.FR)研究中招募,每六个月接受行为、整体、营养和医学评估,并评估认知功能和独立性。纳入研究时,113名患者报告有痴呆家族史,358名患者无痴呆家族史。两组在基线时的任何因素均无统计学差异。随访两年后,每组仍有相似比例的患者接受随访,尽管大多数参数显示有显著恶化,但两组之间无差异,这表明痴呆家族史似乎不会影响AD的进展。

相似文献

1
Family history of dementia does not influence the progression of Alzheimer's disease at two years: results from the REAL.FR Study.痴呆家族史对阿尔茨海默病两年病程无影响:来自REAL.FR研究的结果。
Am J Alzheimers Dis Other Demen. 2006 Mar-Apr;21(2):131-6. doi: 10.1177/153331750602100214.
2
Nutritional status assessment during Alzheimer's disease: results after one year (the REAL French Study Group).阿尔茨海默病患者营养状况评估:一年后的结果(法国REAL研究小组)
J Nutr Health Aging. 2005;9(2):81-4.
3
Weight loss and rapid cognitive decline in community-dwelling patients with Alzheimer's disease.社区居住的阿尔茨海默病患者的体重减轻和认知能力迅速下降。
J Alzheimers Dis. 2012;28(3):647-54. doi: 10.3233/JAD-2011-110713.
4
Long-term progression of Alzheimer's disease in patients under antidementia drugs.抗痴呆药物治疗患者阿尔茨海默病的长期进展。
Alzheimers Dement. 2011 Nov;7(6):579-92. doi: 10.1016/j.jalz.2011.02.009.
5
[Nutritional status and Alzheimer's disease: preliminary results of the REAL.FR study].[营养状况与阿尔茨海默病:REAL.FR研究的初步结果]
Rev Med Interne. 2003 Oct;24 Suppl 3:314s-318s. doi: 10.1016/s0248-8663(03)80689-6.
6
[Behavioral and psychologic symptoms in Alzheimer's disease: results of the REAL.FR study].[阿尔茨海默病的行为和心理症状:REAL.FR研究结果]
Rev Med Interne. 2003 Oct;24 Suppl 3:319s-324s. doi: 10.1016/s0248-8663(03)80690-2.
7
Suitability of the Clinical Dementia Rating-Sum of Boxes as a single primary endpoint for Alzheimer's disease trials.临床痴呆评定量表-盒式评分作为阿尔茨海默病试验单一主要终点的适宜性。
Alzheimers Dement. 2011 Nov;7(6):602-610.e2. doi: 10.1016/j.jalz.2011.01.005. Epub 2011 Jul 13.
8
Prognosis of Alzheimer's disease today: a two-year prospective study in 686 patients from the REAL-FR Study.当今阿尔茨海默病的预后:来自REAL-FR研究的686例患者的两年前瞻性研究
Alzheimers Dement. 2008 Jan;4(1):22-9. doi: 10.1016/j.jalz.2007.10.018.
9
Cardiovascular disease risk factors and progression of Alzheimer's disease.心血管疾病风险因素与阿尔茨海默病的进展
Dement Geriatr Cogn Disord. 2009;27(3):240-6. doi: 10.1159/000203365. Epub 2009 Feb 21.
10
Refining Mild-to-Moderate Alzheimer Disease Screening: A Tool for Clinicians.优化轻至中度阿尔茨海默病筛查:临床医生的工具
J Am Med Dir Assoc. 2016 Oct 1;17(10):913-20. doi: 10.1016/j.jamda.2016.06.005.

引用本文的文献

1
Alzheimer's disease: the strength of association of costs with different measures of disease severity.阿尔茨海默病:成本与不同疾病严重程度衡量指标之间关联的强度。
J Nutr Health Aging. 2010 Oct;14(8):655-63. doi: 10.1007/s12603-010-0312-6.
2
Family history of Alzheimer's disease and hippocampal structure in healthy people.阿尔茨海默病家族史与健康人群的海马结构。
Am J Psychiatry. 2010 Nov;167(11):1399-406. doi: 10.1176/appi.ajp.2010.09111575. Epub 2010 Aug 4.
3
High medical co-morbidity and family history of dementia is associated with lower cognitive function in older patients.高医疗合并症和痴呆家族史与老年患者较低的认知功能相关。
Fam Pract. 2009 Oct;26(5):339-43. doi: 10.1093/fampra/cmp047. Epub 2009 Jul 7.

本文引用的文献

1
Recent data on the natural history of Alzheimer's disease: results from the REAL.FR Study.
J Nutr Health Aging. 2005;9(2):86-93.
2
Impact of nutritional status on the evolution of Alzheimer's disease and on response to acetylcholinesterase inhibitor treatment.营养状况对阿尔茨海默病进展及乙酰胆碱酯酶抑制剂治疗反应的影响。
J Nutr Health Aging. 2005;9(2):75-80.
3
Long-term cholinergic treatment is not associated with greater risk of weight loss during Alzheimer's disease: data from the French REAL.FR cohort.长期胆碱能治疗与阿尔茨海默病期间体重减轻的较高风险无关:来自法国REAL.FR队列的数据。
J Nutr Health Aging. 2005;9(2):69-73.
4
Alteration of a clinically meaningful outcome in the natural history of Alzheimer's disease by cholinesterase inhibition.通过胆碱酯酶抑制改变阿尔茨海默病自然病程中有临床意义的转归。
J Am Geriatr Soc. 2005 Jan;53(1):83-7. doi: 10.1111/j.1532-5415.2005.53015.x.
5
APOE genotype, family history of dementia, and Alzheimer disease risk: a 6-year follow-up study.载脂蛋白E基因型、痴呆家族史与阿尔茨海默病风险:一项6年随访研究
Arch Neurol. 2004 Dec;61(12):1930-4. doi: 10.1001/archneur.61.12.1930.
6
STUDIES OF ILLNESS IN THE AGED. THE INDEX OF ADL: A STANDARDIZED MEASURE OF BIOLOGICAL AND PSYCHOSOCIAL FUNCTION.老年人疾病研究。日常生活活动能力指数:生物和心理社会功能的标准化测量方法。
JAMA. 1963 Sep 21;185:914-9. doi: 10.1001/jama.1963.03060120024016.
7
The REAL.FR research program on Alzheimer's disease and its management: methods and preliminary results.关于阿尔茨海默病及其管理的REAL.FR研究项目:方法与初步结果
J Nutr Health Aging. 2003;7(2):91-6.
8
Variability in annual Mini-Mental State Examination score in patients with probable Alzheimer disease: a clinical perspective of data from the Consortium to Establish a Registry for Alzheimer's Disease.可能患有阿尔茨海默病患者的年度简易精神状态检查表得分的变异性:来自阿尔茨海默病注册协会数据的临床视角
Arch Neurol. 1999 Jul;56(7):857-62. doi: 10.1001/archneur.56.7.857.
9
The Mini Nutritional Assessment (MNA) and its use in grading the nutritional state of elderly patients.微型营养评定法(MNA)及其在老年患者营养状况分级中的应用。
Nutrition. 1999 Feb;15(2):116-22. doi: 10.1016/s0899-9007(98)00171-3.
10
Predicting rate of cognitive decline in probable Alzheimer's disease.预测疑似阿尔茨海默病患者的认知衰退速度。
Brain Cogn. 1996 Jul;31(2):133-47. doi: 10.1006/brcg.1996.0038.